InnovAge Holding Corp.

INNV

US45784A1043

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.91 ^USD	+2.89%		-1.01%	-34.83%

Apr. 24	InnovAge Holding Corp. Launches PACE Center in Los Angeles	CI
Mar. 13	JPMorgan Adjusts Price Target on InnovAge to $6 From $7, Maintains Neutral Rating	MT

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2024

February 06, 2024 at 04:05 pm EST

InnovAge Holding Corp. provided earnings guidance for the full fiscal year 2024. For the year, the company expected total revenues of $725 million to $775 million a year ago.

Latest news about InnovAge Holding Corp.

InnovAge Holding Corp. Launches PACE Center in Los Angeles	Apr. 24	CI
JPMorgan Adjusts Price Target on InnovAge to $6 From $7, Maintains Neutral Rating	Mar. 13	MT
InnovAge Holding Corp. Launches New Center in Tampa, its First in the State of Florida	Mar. 04	CI
Transcript : InnovAge Holding Corp. - Analyst/Investor Day	Feb. 27
Goldman Sachs Trims Price Target on InnovAge Holding to $7 From $8, Maintains Neutral Rating	Feb. 08	MT
Transcript : InnovAge Holding Corp., Q2 2024 Earnings Call, Feb 06, 2024	Feb. 06
(INNV) INNOVAGE Expects Fiscal Year 2023 Revenue Range $725M - $775M	Feb. 06	MT
Earnings Flash (INNV) INNOVAGE Posts Q2 Revenue $188.9M, vs. Street Est of $184M	Feb. 06	MT
InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2024	Feb. 06	CI
InnovAge Holding Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 06	CI
InnovAge Acquires Two PACE Programs in California From ConcertoCare	Dec. 01	MT
InnovAge Holding Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 07	CI
Transcript : InnovAge Holding Corp., Q1 2024 Earnings Call, Nov 07, 2023	Nov. 07
Earnings Flash (INNV) INNOVAGE Reports Q1 Revenue $182.5M, vs. Street Est of $178.4M	Nov. 07	MT
InnovAge Holding Appoints New Chief Nursing Officer	23-10-02	MT
Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer	23-10-02	CI
JPMorgan Adjusts InnovAge Price Target to $7 From $8, Maintains Neutral Rating	23-09-18	MT
InnovAge Holding Corp.(NasdaqGS:INNV) dropped from S&P Global BMI Index	23-09-18	CI
Earnings Flash (INNV) INNOVAGE Reports Q4 Revenue $176.9M, vs. Street Est of $175.8M	23-09-12	MT
InnovAge Holding Corp. Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-12	CI
Transcript : InnovAge Holding Corp., Q4 2023 Earnings Call, Sep 12, 2023	23-09-12
InnovAge Holding Corp. Provides Full Fiscal Year 2024 Financial Guidance	23-09-12	CI
InnovAge Holding Corp. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	23-09-12	CI
North American Morning Briefing : Stock Futures -2-	23-09-12	DJ
MORNING BID AMERICAS-Risk and rates moving in tandem	23-09-12	RE

InnovAge Holding Corp. is a healthcare delivery platform. It is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE) program, it fulfills a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who design, manage and coordinate each participants personalized care plan.

Sector

Healthcare Facilities & Services

Calendar

2024-05-06 - Q3 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for InnovAge Holding Corp.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

3.91 USD

Average target price

6.5 USD

Spread / Average Target

+66.24%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
INNOVAGE HOLDING CORP.	-34.83%	531M
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-3.06%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
EUROFINS SCIENTIFIC SE	-3.97%	11.66B
FRESENIUS MEDICAL CARE AG	-1.42%	11.72B
PURE HEALTH HOLDING	-31.75%	11.77B

Other Healthcare Facilities & Services